Anthropic Financials: July 2026 Update

Anthropic’s headline numbers are unchanged this month: the $965B post-money valuation set by the Series H in late May and the ~$47B annualized revenue run-rate reported through May 2026 remain the current markers. The story this month is operational.

Key points

• Valuation unchanged at $965B post-money (Series H, 2026-05-28), per Sacra data updated 2026-07-10.
• Revenue run-rate unchanged at ~$47B annualized, last measured May 2026.
• Anthropic signed a 20-year data-centre lease with TeraWulf in early July, signaling long-horizon infrastructure commitment.
• Anthropic alleged that Alibaba illicitly extracted Claude model capabilities through model distillation, a notable IP dispute with geopolitical dimensions.
• A new AI drug-discovery initiative targeting neglected diseases was announced, pointing toward vertical expansion beyond the core API and Claude products.

Where does the valuation stand?

At $965B, Anthropic is the highest-valued private AI lab by Sacra’s estimates, edging out OpenAI’s $852B mark (as of April 2026). The Series H closed May 28 at that figure, co-led by Altimeter Capital, Dragoneer, Greenoaks, and Sequoia Capital, with Capital Group, Coatue, D1 Capital, GIC, ICONIQ, and XN joining. The round included $15B of previously committed hyperscaler investment, of which $5B came from Amazon.

No new round has been reported since. Sacra confirmed the $965B figure as current through July 10, 2026. Absent a new transaction, the valuation is a May 2026 data point, not a live market price.

How does revenue look?

The $47B annualized run-rate, measured at the end of May 2026, capped a striking growth sequence: $9B at end-2025, $14B in February 2026, $19B in early March, $30B in early April, and $47B by May. That is roughly a 5x increase in five months.

No June or July revenue data has been published. The next update that moves this number will likely come from Sacra or a primary disclosure in August. For now, $47B is the last known figure, not a July reading.

On the business side, the May 2026 Sacra snapshot showed 300,000-plus business customers, more than 1,000 accounts spending over $1M annually, and eight Fortune 10 customers. Roughly 80% of revenue derives from business clients.

How do the comparables look?

Among private AI labs, Anthropic sits above OpenAI on both valuation ($965B vs. $852B) and reported revenue run-rate ($47B vs. $25B), though OpenAI’s revenue figure dates to February 2026 and may have grown since.

Among public hyperscalers, the context is different in scale but useful for framing. As of July 26, Amazon trades at $232.11, Alphabet at $319.74, Microsoft at $381.70, and Nvidia at $206.84. These are the infrastructure and platform players Anthropic both depends on and, at the margin, competes with as it builds its own compute capacity.

IPO watch

The Series H note described that round as likely the last private financing before an IPO. No filing or public timeline has been announced. The TeraWulf lease, covering 20 years, suggests Anthropic is planning for an extended independent operating horizon regardless of when a public offering occurs. A long-dated infrastructure commitment of that kind is unusual for a company expecting a near-term liquidity event, or alternatively, it reflects the capital intensity required to stay competitive at the frontier.

The Alibaba distillation allegation is worth watching from an IPO-readiness perspective. IP protection and model security are likely to feature prominently in any S-1 risk-factor section, and a high-profile dispute with a major Chinese technology company sharpens that narrative considerably.

The drug-discovery push is early-stage, but vertical expansion into life sciences mirrors moves by other foundation-model companies seeking to demonstrate that general-purpose AI can anchor specialized, high-margin verticals. It is unlikely to move near-term revenue, but it adds to the story Anthropic will tell public-market investors about addressable market.